Reaction Details |
| Report a problem with these data |
Target | Nuclear receptor ROR-alpha |
---|
Ligand | BDBM50050083 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1457465 (CHEMBL3367605) |
---|
EC50 | >10000±n/a nM |
---|
Citation | Fauber, BP; René, O; de Leon Boenig, G; Burton, B; Deng, Y; Eidenschenk, C; Everett, C; Gobbi, A; Hymowitz, SG; Johnson, AR; La, H; Liimatta, M; Lockey, P; Norman, M; Ouyang, W; Wang, W; Wong, H Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists. Bioorg Med Chem Lett24:3891-7 (2014) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Nuclear receptor ROR-alpha |
---|
Name: | Nuclear receptor ROR-alpha |
Synonyms: | NR1F1 | Nuclear receptor RZR-alpha | Nuclear receptor subfamily 1 group F member 1 | RAR-related orphan receptor A | RORA | RORA_HUMAN | RZRA | Retinoid-related orphan receptor-alpha |
Type: | PROTEIN |
Mol. Mass.: | 58976.26 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_101591 |
Residue: | 523 |
Sequence: | MESAPAAPDPAASEPGSSGADAAAGSRETPLNQESARKSEPPAPVRRQSYSSTSRGISVT
KKTHTSQIEIIPCKICGDKSSGIHYGVITCEGCKGFFRRSQQSNATYSCPRQKNCLIDRT
SRNRCQHCRLQKCLAVGMSRDAVKFGRMSKKQRDSLYAEVQKHRMQQQQRDHQQQPGEAE
PLTPTYNISANGLTELHDDLSNYIDGHTPEGSKADSAVSSFYLDIQPSPDQSGLDINGIK
PEPICDYTPASGFFPYCSFTNGETSPTVSMAELEHLAQNISKSHLETCQYLREELQQITW
QTFLQEEIENYQNKQREVMWQLCAIKITEAIQYVVEFAKRIDGFMELCQNDQIVLLKAGS
LEVVFIRMCRAFDSQNNTVYFDGKYASPDVFKSLGCEDFISFVFEFGKSLCSMHLTEDEI
ALFSAFVLMSADRSWLQEKVKIEKLQQKIQLALQHVLQKNHREDGILTKLICKVSTLRAL
CGRHTEKLMAFKAIYPDIVRLHFPPLYKELFTSEFEPAMQIDG
|
|
|
BDBM50050083 |
---|
n/a |
---|
Name | BDBM50050083 |
Synonyms: | CHEMBL3317833 | US9216988, 101 |
Type | Small organic molecule |
Emp. Form. | C24H33N3O3S |
Mol. Mass. | 443.602 |
SMILES | CC(C)CN(Cc1ccc(cc1)N1CCN(CC1)C(C)=O)S(=O)(=O)Cc1ccccc1 |
Structure |
|